Cargando…

Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma

BACKGROUND: There is no standard therapeutic procedure for the hepatocellular carcinoma (HCC) in patients with poor hepatic reserve function. With the approval of newly developed chemotherapeutic agent of miriplatin, we have firstly conducted the phase I study of CDDP powder (DDP-H) and miriplatin c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamimura, Kenya, Suda, Takeshi, Tamura, Yasushi, Takamura, Masaaki, Yokoo, Takeshi, Igarashi, Masato, Kawai, Hirokazu, Yamagiwa, Satoshi, Nomoto, Minoru, Aoyagi, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482551/ https://www.ncbi.nlm.nih.gov/pubmed/22994941 http://dx.doi.org/10.1186/1471-230X-12-127

Ejemplares similares

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial
por: Kamimura, Kenya, et al.
Publicado: (2017)

A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
por: Osaki, Akihiko, et al.
Publicado: (2013)

Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two cases
por: Ogawa, Kohei, et al.
Publicado: (2017)

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017)

Effective prevention of sorafenib-induced hand–foot syndrome by dried-bonito broth
por: Kamimura, Kenya, et al.
Publicado: (2018)

Presence of Antibodies against Self Human Leukocyte Antigen Class II Molecules in Autoimmune Hepatitis
por: Yamagiwa, Satoshi, et al.
Publicado: (2014)

Effect of transarterial chemoembolization with miriplatin plus epirubicin on local control of hepatocellular carcinoma: a retrospective comparison with miriplatin monotherapy
por: Hashimoto, Naoko, et al.
Publicado: (2013)

Renal Impairment in Chronic Hepatitis B: A Review
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Liver lobe-specific hydrodynamic gene delivery to baboons: A preclinical trial for hemophilia gene therapy
por: Kamimura, Kenya, et al.
Publicado: (2023)

Spontaneous regression of hepatocellular carcinoma: A mini-review
por: Sakamaki, Akira, et al.
Publicado: (2017)

Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial
por: Ikeda, Masafumi, et al.
Publicado: (2017)

Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients
por: Kamimura, Kenya, et al.
Publicado: (2019)

Bleeding from a Small-Intestinal Ulcer Associated with Chronic Hepatitis C
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Hepatic Angiomyolipoma: Diagnostic Findings and Management
por: Kamimura, Kenya, et al.
Publicado: (2012)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C
por: Yamagiwa, Satoshi, et al.
Publicado: (2017)

Adipose most abundant 2 protein is a predictive marker for cisplatin sensitivity in cancers
por: Kamimura, Kenya, et al.
Publicado: (2021)

Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Safety Assessment of Liver-Targeted Hydrodynamic Gene Delivery in Dogs
por: Kamimura, Kenya, et al.
Publicado: (2014)

Rational arrangement of measuring shear wave speed in the liver
por: Yokoo, Takeshi, et al.
Publicado: (2019)

Hemodynamics of a hydrodynamic injection
por: Kanefuji, Tsutomu, et al.
Publicado: (2014)

Site-Specific Impact of a Regional Hydrodynamic Injection: Computed Tomography Study during Hydrodynamic Injection Targeting the Swine Liver
por: Yokoo, Takeshi, et al.
Publicado: (2015)

Hydrodynamic Delivery: Characteristics, Applications, and Technological Advances
por: Suda, Takeshi, et al.
Publicado: (2023)

Parameters Affecting Image-guided, Hydrodynamic Gene Delivery to Swine Liver
por: Kamimura, Kenya, et al.
Publicado: (2013)

A Case of Hepatorenal Syndrome and Abdominal Compartment Syndrome with High Renal Congestion
por: Kamimura, Hiroteru, et al.
Publicado: (2017)

Immunohistochemical Character of Hepatic Angiomyolipoma: For Its Management
por: Kobayashi, Yuka, et al.
Publicado: (2013)

Longitudinal increase in albumin–bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2022)

Effective Prevention of Liver Fibrosis by Liver-targeted Hydrodynamic Gene Delivery of Matrix Metalloproteinase-13 in a Rat Liver Fibrosis Model
por: Abe, Hiroyuki, et al.
Publicado: (2016)

Combination Therapy by Transarterial Injection of Miriplatin-Iodized Oil Suspension with Microwave Ablation for Medium-Sized Hepatocellular Carcinoma: the Preliminary Experience
por: Kanaya, Motoma, et al.
Publicado: (2022)

Gene Therapy for Pancreatic Diseases: Current Status
por: Kamimura, Kenya, et al.
Publicado: (2018)

A case report of psychiatric symptoms following direct-acting antiviral and ribavirin combination therapy for chronic hepatitis C in a patient with innate anxiety
por: Sakamaki, Akira, et al.
Publicado: (2019)

Gene Therapy for Liver Cancers: Current Status from Basic to Clinics
por: Kamimura, Kenya, et al.
Publicado: (2019)

The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity.
por: Ohkawa, K., et al.
Publicado: (1988)

Liver-targeted hydrodynamic gene therapy: Recent advances in the technique
por: Yokoo, Takeshi, et al.
Publicado: (2016)

Effects of Fibrotic Tissue on Liver-targeted Hydrodynamic Gene Delivery
por: Kobayashi, Yuji, et al.
Publicado: (2016)

Effect of TTLL6 expression on CDDP sensitivity of EC109/CDDP cells in hypoxia/acidosis microenvironment
por: Qiu, Yang, et al.
Publicado: (2020)

Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge
por: Kamimura, Hiroteru, et al.
Publicado: (2021)

TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer
por: Nishibeppu, Keiji, et al.
Publicado: (2021)

A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy
por: Shoji, Tadahiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lf5ut10tn6dk9r92eoq262lemh